CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Impact of CECL Adoption	Common Stock	Additional paid-in capital	Retained earnings	Retained earnings Impact of CECL Adoption	Treasury stock	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2021			4,493,655
Beginning balances at Dec. 31, 2021	$ 84,341		$ 9,934	$ 1,769	$ 78,350		$ (4,160)	$ (1,552)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,413				5,413
Other comprehensive (loss) income	(26,847)							(26,847)
Dividend reinvestment plan (in shares)			928
Dividend reinvestment plan	28			20			8
Cash dividends declared	(3,146)				(3,146)
Stock based compensation expense (in shares)			2,879
Stock based compensation expense	236		$ 6	230
Purchase of treasury stock (in shares)			(2,650)
Purchase of treasury stock	(79)						(79)
Ending balance (in shares) at Jun. 30, 2022			4,494,812
Ending balances at Jun. 30, 2022	59,946		$ 9,940	2,019	80,617		(4,231)	(28,399)
Beginning balance (in shares) at Dec. 31, 2021			4,493,655
Beginning balances at Dec. 31, 2021	84,341		$ 9,934	1,769	78,350		(4,160)	(1,552)
Ending balance (in shares) at Dec. 31, 2022			4,508,587
Ending balances at Dec. 31, 2022	$ 55,220	$ 37	$ 9,965	2,225	84,669	$ 37	(4,220)	(37,419)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Beginning balance (in shares) at Mar. 31, 2022			4,493,170
Beginning balances at Mar. 31, 2022	$ 69,417		$ 9,937	1,878	79,259		(4,231)	(17,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,931				2,931
Other comprehensive (loss) income	(10,973)							(10,973)
Dividend reinvestment plan (in shares)			512
Dividend reinvestment plan	15			11			4
Cash dividends declared	(1,573)				(1,573)
Stock based compensation expense (in shares)			1,280
Stock based compensation expense	133		$ 3	130
Purchase of treasury stock (in shares)			(150)
Purchase of treasury stock	(4)						(4)
Ending balance (in shares) at Jun. 30, 2022			4,494,812
Ending balances at Jun. 30, 2022	59,946		$ 9,940	2,019	80,617		(4,231)	(28,399)
Beginning balance (in shares) at Dec. 31, 2022			4,508,587
Beginning balances at Dec. 31, 2022	55,220	$ 37	$ 9,965	2,225	84,669	$ 37	(4,220)	(37,419)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,676				5,676
Other comprehensive (loss) income	1,168							1,168
Dividend reinvestment plan (in shares)			1,728
Dividend reinvestment plan	41			26			15
Cash dividends declared	(3,246)				(3,246)
Stock based compensation expense (in shares)			1,788
Stock based compensation expense	218		$ 4	214
Purchase of treasury stock (in shares)			(2,530)
Purchase of treasury stock	(60)						(60)
Ending balance (in shares) at Jun. 30, 2023			4,509,573
Ending balances at Jun. 30, 2023	59,054		$ 9,969	2,465	87,136		(4,265)	(36,251)
Beginning balance (in shares) at Mar. 31, 2023			4,506,950
Beginning balances at Mar. 31, 2023	60,592		$ 9,965	2,353	86,060		(4,272)	(33,514)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,699				2,699
Other comprehensive (loss) income	(2,737)							(2,737)
Dividend reinvestment plan (in shares)			835
Dividend reinvestment plan	18			11			7
Cash dividends declared	(1,623)				(1,623)
Stock based compensation expense (in shares)			1,788
Stock based compensation expense	105		$ 4	101
Ending balance (in shares) at Jun. 30, 2023			4,509,573
Ending balances at Jun. 30, 2023	$ 59,054		$ 9,969	$ 2,465	$ 87,136		$ (4,265)	$ (36,251)